ZIMMER BIOMET HOLDINGS, INC.
Loading stock data...
Key Financial Metrics (TTM | FY 2024)
$8.01B
Revenue
$805.20M
Net Income
4.03
EPS (Diluted)
-
Free Cash Flow
Profitability
Gross Margin
71.44%
Operating Margin
16.63%
Net Profit Margin
10.05%
EBITDA
$3.19B
Returns & Efficiency
Return on Assets (ROA)
3.43%
Return on Equity (ROE)
6.31%
Gross Profit
$5.72B
Operating Income
$1.33B
Financial Health
Total Assets
$23.49B
Total Debt
$7.51B
Debt to Equity
0.84x
Current Ratio
2.43
Debt Analysis
Debt to EBITDA
-
Debt to Free Cash Flow
-
Cash & Equivalents
-
Net Debt
-
Capital Returns
Return on Invested Capital (ROIC)
-
Invested Capital
-
Stockholders Equity
-
Revenue Growth
-
Market Valuation
Market Cap
-
P/E Ratio
-
Price to Book
-
EPS (Diluted)
$4.03
Quick Access Filings
10-K
Annual Report
Loading...
10-Q
Quarterly Report
Loading...
8-K
Recent News
Loading...
Company Data Library
Earnings Transcripts
Loading...
Press Releases
Loading...
Filing Sections
Loading...
Financial Charts Annual (10-K)
Interactive financial visualizations
Show:
Revenue & Income Trends
Revenue & Profit
Profit Margins
Balance Sheet Breakdown
Assets Composition
Capital Structure
Cash Flow Analysis
Cash Flow Components
Free Cash Flow
Growth & Performance
Revenue Growth Rate (YoY %)
Key Ratio Trends
Insider Transactions
Neutral
Open Market Buys: -
Open Market Sales: -
Option Exercise & Sale: -
Net: -
Loading...
Loading insider transactions...
My Notes & Files
Personal Notes
Attached Files
Loading...
SEC Filings by Category
Insider Trading Activity
Neutral
0 Buys $0
0 Sales $0
0 Exercises $0
Net: $0
| Insider | Title | Date | Type | Shares | Price | Value |
|---|
Company Information
| Business Address |
345 EAST MAIN STREET
WARSAW, IN 46580 |
| Phone | 5742676131 |
| Incorporated | DE, US |
| EIN | 134151777 |
| Fiscal Year End | 1231 |
| Shares Outstanding | 198.10M |
| Stockholders' Equity | $12.76B |
| Cash & Equivalents | $1.29B |
Recent Filings
View All
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-03-10
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-03-10
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-03-10
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-03-10
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-03-10
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-03-10
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-03-10
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-02-24
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-02-24
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-02-24
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-02-24
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-02-24
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-02-24
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-02-24
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-02-24
Local
Financial Statistics
Valuation
Market Cap
-
P/E Ratio (TTM)
-
Price to Book
-
EV/Revenue
-
EV/EBITDA
-
Profitability
Gross Margin
71.4%
Operating Margin
16.6%
Net Margin
10.1%
ROE
6.3%
ROA
3.4%
Leverage & Liquidity
Debt to Equity
0.84
Current Ratio
2.43
Total Debt
$7.51B
Total Assets
$23.49B
Stockholders' Equity
$12.76B
Income Statement (FY 2024)
Revenue
$8.01B
Gross Profit
$5.72B
Operating Income
$1.33B
Net Income
$805.20M
EPS (Diluted)
$4.03
Cash Flow (FY 2024)
Free Cash Flow
-
Cash & Equivalents
$1.29B
Revenue Growth
4.3%
Loading...
Loading management data...
Loading...
Loading board of directors...
Loading...
Loading institutional holders...